Pulmonary Hypertension Trial, Recruiting NCT07131241 Sponsor: First Affiliated Hospital of Fujian Medical University Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07131241
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People whose heart ultrasound (echocardiogram) shows elevated pressure in the artery connecting the heart to the lungs (a reading of 35 mmHg or higher)
  • People who have given written agreement to take part in the study

Who may not be able to join:

  • People with serious liver or kidney problems
  • People currently receiving active treatment for cancer
  • People with a serious, active infection
  • People with an active autoimmune disease (a condition where the immune system attacks the body)
  • People who have had major surgery within the past 3 months
  • People who are pregnant or breastfeeding
  • People with a severe psychiatric condition that would make it difficult to follow the study's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dajun Chai, MD, First Affiliated Hospital of Fujian Medical University

Phone: 0086059187981637

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital of Fujian Medical University
Registry
ClinicalTrials.gov
Start date
27 June 2025
Est. completion
30 June 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Time to clinical worsening; All-cause mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov